Digital Health | FemTech | Healthcare Software & AI | Industry Insights | MedTech | Medical Imaging & AI | Podcasts | Women's Health

Xella Health on AI and the Future of Women’s Health

October 29, 2026 By Klaudia Topa

MedTech Tea Podcast | Klaudia Topa in conversation with Kelly Lacob, CEO of Xella Health

Can AI help close the gaps that still exist in women’s healthcare?

AI is already changing how healthcare data is analysed, how conditions are detected and how clinicians make decisions. In women’s health, however, the technology is developing against a backdrop of longstanding gaps in research, data and female-specific approaches to care.

In the first episode of MedTech Tea, Klaudia Topa speaks with Kelly Lacob, CEO of Xella Health, about what needs to change.

Xella Health is building a clinical intelligence and care platform specifically for women’s health, bringing together biomarkers, clinical history and other health data to identify patterns that may otherwise be missed and support more personalised care.

The conversation looks at the opportunity for AI to improve earlier detection and make better use of the health information already available, while also confronting some of the harder questions around bias, clinical validation and trust.

Where can AI make a meaningful difference in women’s health?

One of the central themes of the episode is the difference between having more healthcare data and being able to do something useful with it.

Kelly explains how gaps in women’s health extend beyond the amount of research available. Existing information is not always interpreted through female-specific clinical protocols or connected across different areas of health.

That becomes particularly important when symptoms or conditions span several systems within the body. Xella’s approach is designed to examine those connections, looking across areas such as reproductive, hormonal, cardiovascular, and metabolic health rather than evaluating each piece of information in isolation.

Kelly also talks through an example of how combining patient history with biomarker data could help identify underlying factors affecting fertility and lead to a more focused care pathway.

This raises a wider challenge: useful clinical AI depends on more than the volume of data available. Teams need to determine which signals are meaningful and understand where evidence is limited to translate those findings into something clinicians and patients can act on.

Building healthcare AI that clinicians can trust

Historical healthcare datasets can contain gaps of their own, particularly when populations have been underrepresented in research. Training an AI system on that information without understanding those limitations risks carrying existing problems into new technology.

Kelly discusses how Xella approaches this by considering the populations represented within its data and research, identifying areas where evidence is still limited and distinguishing established clinical guidance from emerging research.

The role of clinicians remains important too. Xella currently uses a clinician-in-the-loop approach, with healthcare professionals reviewing AI-generated insights and proposed care plans before focusing their time on clinical judgement and patient interaction.

For Kelly, the opportunity lies in using AI to connect information that could be difficult for an individual clinician to process at scale, while giving healthcare professionals more time for the parts of care that require human expertise and interaction.

From personal experience to building Xella Health

The episode also moves beyond the technology into the reality of building a women’s health company. Kelly describes herself as a reluctant founder and explains how losing her mother to ovarian cancer became the catalyst for Xella Health. Alongside her own experiences of delayed diagnoses, it shaped her view of what earlier detection and better-supported women’s healthcare could look like.

She and Klaudia discuss the decisions that come with building a healthcare startup, from deciding where limited resources can have the greatest impact to balancing speed with the evidence and validation required in a clinical setting. Kelly also shares her experience raising investment as a female founder in women’s health and why she believes investors still need a stronger understanding of the scale of the opportunity within the market.

Key topics covered

  • Why women can experience significant delays in diagnosis and where female-specific clinical protocols are still lacking
  • How Xella Health combines biomarkers and broader patient data to build a more connected view of women’s health
  • The role AI could play in identifying patterns, supporting earlier detection and improving personalised care
  • Managing bias when historical healthcare research does not adequately represent every population
  • Why clinical evidence, validation, and transparency are central to healthcare AI adoption
  • Kelly’s personal motivation for co-founding Xella Health and her experience leading the business
  • Balancing ambitious healthcare innovation with the realities of funding and startup growth
  • What the next five years could hold for Xella Health and AI-enabled women’s healthcare

About MedTech Tea

MedTech Tea is hosted by Klaudia Topa, Medical Imaging AI and Healthcare AI recruitment specialist at Established Search. Through conversations with founders, executives and other people working across healthcare technology, Klaudia explores how AI is being developed and applied within healthcare, alongside the people and decisions behind the companies bringing new technologies to market.